New DNA testing revealed a potential alternative suspect Grimsby
A Grimsby man who spent 17 years in jail for rape has seen his convictions referred to the Court of Appeal after new DNA testing revealed a potential alternative suspect.
In light of new information. Greater Manchester Police said they had arrested a 48-year-old man from Exeter on suspicion of rape who has since been released under investigation, according to the BBC. Andy added: “The trial that resulted in my wrongful conviction felt like a slow motion car crash – I just couldn’t think of any way to stop it.
Although this new evidence does not prove that the man on the DNA database committed these offences, the CCRC has passed it onto Greater Manchester Police for them to consider further.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Salford rape: New DNA sparks appeal hope for 2003 convictionAndrew Malkinson spent 17 years in jail for raping a woman but has always maintained his innocence.
Lire la suite »
Grimsby girl, 9, beats cancer with transplant from younger sisterRuby has been recognised with a special national award
Lire la suite »
Logan Mwangi's mum fails in bid to challenge murder convictionThe Court of Appeal sitting in Swansea Crown Court on Wednesday heard the renewed application.
Lire la suite »
Louise Redknapp: new man, new startLouise Redknapp has got her mojo back following her split from Jamie Redknapp in 2017. Read more on heatworld.
Lire la suite »
GOP Rep. George Santos Should Resign From Congress, New York State Voters Say in New PollSome 59% of registered Empire State voters say George Santos, who admitted he lied and is facing multiple investigations, should resign, according to the latest survey.
Lire la suite »
New study evaluates the safety profile of the BNT162b2 vaccine in New ZealandResearchers determined the association between adverse events of special interest (AESIs) following BNT162b2 vaccination, a coronavirus disease 2019 (COVID-19) vaccine based on the messenger ribonucleic acid (mRNA) technology.
Lire la suite »